Clinical trial · Observational
Study on Thrombosis Therapy in German Cancer Patients
NCT01559883CI-TRIAL-00015399completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to document the flow of German patients with cancer and acute deep vein thrombosis from first visit to diagnosis and treatment, the applied diagnostic procedures, and therapy modalities.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Deep Vein Thrombosis | — | UNRESOLVED | — |
| Pulmonary Embolism | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| no intervention is being made | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- all eligible patients
- description
- there is only 1 Cohort in which all patients participating in this NIS are included
- interventionNames
- Other: no intervention is being made
Primary outcomes (1)
- measure
- treatment time on low molecular weight heparin
- timeFrame
- 1 year
Secondary outcomes (2)
- measure
- patient pathways
- timeFrame
- 1 year
- description
- data collection on patient pathway: who is the referring physician, physician who diagnoses deep vein thrombosis (DVT)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patient with cancer and acute deep vein thrombosis and/or pulmonary embolism Exclusion Criteria: * life expectancy less that 6 months * age less that 18 years
References
Publications (0)
Data not yet available
No reference posted for this study.